Show simple item record

dc.contributor.authorBaslet, Gaston
dc.date.accessioned2013-04-22T18:54:46Z
dc.date.issued2012
dc.identifier.citationBaslet, Gaston. 2012. Psychogenic nonepileptic seizures: A treatment review. What have we learned since the beginning of the millennium? Neuropsychiatric Disease and Treatment 8:585-598.en_US
dc.identifier.issn1176-6328en_US
dc.identifier.issn1178-2021en_US
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:10579237
dc.description.abstractPsychogenic nonepileptic seizures (PNES) can significantly affect an individual’s quality of life, the health care system, and even society. The first decade of the new millennium has seen renewed interest in this condition, but etiological understanding and evidence-based treatment availability remain limited. After the diagnosis of PNES is established, the first therapeutic step includes a presentation of the diagnosis that facilitates engagement in treatment. The purpose of this review is to present the current evidence of treatments for PNES published since the year 2000 and to discuss further needs for clinical treatment implementation and research. This article reviews clinical trials that have evaluated the efficacy of structured, standardized psychotherapeutic and psychopharmacological interventions. The primary outcome measure in clinical trials for PNES is event frequency, although it is questionable whether this is the most accurate indicator of functional recovery. Cognitive behavioral therapy has evidence of efficacy, including one pilot randomized, controlled trial where cognitive behavioral therapy was compared with standard medical care. The antidepressant sertraline did not show a significant difference in event frequency change when compared to placebo in a pilot randomized, double-blind, controlled trial, but it did show a significant pre- versus posttreatment decrease in the active arm. Other interventions that have shown efficacy in uncontrolled trials include augmented psychodynamic interpersonal psychotherapy, group psychodynamic psychotherapy, group psychoeducation, and the antidepressant venlafaxine. Larger clinical trials of these promising treatments are necessary, while other psychotherapeutic interventions such as hypnotherapy, mindfulness-based therapies, and eye movement desensitization and reprocessing may deserve exploration. Flexible delivery of treatment that considers the heterogeneous backgrounds of patients is emphasized as necessary for successful outcomes in clinical practice.en_US
dc.language.isoen_USen_US
dc.publisherDove Medical Pressen_US
dc.relation.isversionofdoi:10.2147/NDT.S32301en_US
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523560/pdf/en_US
dash.licenseLAA
dc.subjectconversion disorderen_US
dc.subjecttherapeuticsen_US
dc.subjectclinical trialsen_US
dc.subjectpsychotherapeutic interventionsen_US
dc.subjectpsychopharmacological interventionsen_US
dc.titlePsychogenic Nonepileptic Seizures: A Treatment Review. What Have We Learned Since the Beginning of the Millennium?en_US
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden_US
dc.relation.journalNeuropsychiatric Disease and Treatmenten_US
dash.depositing.authorBaslet, Gaston
dc.date.available2013-04-22T18:54:46Z
dc.identifier.doi10.2147/NDT.S32301*
dash.contributor.affiliatedBaslet, Gaston


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record